244 related articles for article (PubMed ID: 22269992)
1. [Sacral neuromodulation for neurogenic bladder dysfunction].
Kessler TM; Wöllner J; Kozomara M; Mordasini L; Mehnert U
Urologe A; 2012 Feb; 51(2):179-83. PubMed ID: 22269992
[TBL] [Abstract][Full Text] [Related]
2. [Sacral neuromodulation in urology. The emperor's new clothes or effective high-tech medicine?].
Hoda MR; Fornara P
Urologe A; 2010 Oct; 49(10):1254-9. PubMed ID: 20859609
[TBL] [Abstract][Full Text] [Related]
3. The role of neuromodulation in patients with neurogenic overactive bladder.
Lay AH; Das AK
Curr Urol Rep; 2012 Oct; 13(5):343-7. PubMed ID: 22865208
[TBL] [Abstract][Full Text] [Related]
4. [Sacral neuromodulation in under- and overactive detrusor-quo vadis? : Principles and developments].
Girtner F; Burger M; Mayr R
Urologe A; 2019 Jun; 58(6):634-639. PubMed ID: 31139864
[TBL] [Abstract][Full Text] [Related]
5. Urodynamic findings during the filling phase in neurogenic bladder patients with or without vesicoureteral reflux who have undergone sacral neuromodulation.
Chen G; Liao L; Wang Y; Ying X
Neurourol Urodyn; 2020 Jun; 39(5):1410-1416. PubMed ID: 32282088
[TBL] [Abstract][Full Text] [Related]
6. Protocol for a randomized, placebo-controlled, double-blind clinical trial investigating sacral neuromodulation for neurogenic lower urinary tract dysfunction.
Knüpfer SC; Liechti MD; Mordasini L; Abt D; Engeler DS; Wöllner J; Pannek J; Kiss B; Burkhard FC; Schneider MP; Miramontes E; Kessels AG; Bachmann LM; Kessler TM
BMC Urol; 2014 Aug; 14():65. PubMed ID: 25123172
[TBL] [Abstract][Full Text] [Related]
7. The value of urodynamic tools to guide patient selection in sacral neuromodulation.
Drossaerts J; Rademakers K; van Koeveringe G; Van Kerrebroeck P
World J Urol; 2015 Nov; 33(11):1889-95. PubMed ID: 25680936
[TBL] [Abstract][Full Text] [Related]
8. [Results of sacral nerve modulation for treatment of overactive bladder].
Braun PM; Böhler G
Urologe A; 2006 Jul; 45(7):835-40. PubMed ID: 16773383
[TBL] [Abstract][Full Text] [Related]
9. PNE versus 1st stage tined lead procedure: a direct comparison to select the most sensitive test method to identify patients suitable for sacral neuromodulation therapy.
Leong RK; De Wachter SG; Nieman FH; de Bie RA; van Kerrebroeck PE
Neurourol Urodyn; 2011 Sep; 30(7):1249-52. PubMed ID: 21404317
[TBL] [Abstract][Full Text] [Related]
10. Sacral Neuromodulation: Device Improvement and Current Applications in Urology.
Spilotros M; Gerbasi S; Lasorsa F; de Rienzo G; Balducci L; Ditonno P; Lucarelli G
Medicina (Kaunas); 2024 Mar; 60(3):. PubMed ID: 38541235
[TBL] [Abstract][Full Text] [Related]
11. Sacral neuromodulation: No more skiing?
Wöllner J; Pannek J
Scand J Urol; 2016; 50(2):132-3. PubMed ID: 26754577
[TBL] [Abstract][Full Text] [Related]
12. Video-urodynamics efficacy of sacral neuromodulation for neurogenic bladder guided by three-dimensional imaging CT and C-arm fluoroscopy: a single-center prospective study.
Shan S; Zhu W; Zhang G; Zhang Q; Che Y; Wen J; Wang Q
Sci Rep; 2022 Sep; 12(1):16306. PubMed ID: 36175471
[TBL] [Abstract][Full Text] [Related]
13. Intravesical electrostimulation versus sacral neuromodulation for incomplete spinal cord patients suffering from neurogenic non-obstructive urinary retention.
Lombardi G; Musco S; Celso M; Ierardi A; Nelli F; Del Corso F; Del Popolo G
Spinal Cord; 2013 Jul; 51(7):571-8. PubMed ID: 23628893
[TBL] [Abstract][Full Text] [Related]
14. Results of a prospective, multicenter study evaluating quality of life, safety, and efficacy of sacral neuromodulation at twelve months in subjects with symptoms of overactive bladder.
Noblett K; Siegel S; Mangel J; Griebling TL; Sutherland SE; Bird ET; Comiter C; Culkin D; Bennett J; Zylstra S; Kan F; Berg KC
Neurourol Urodyn; 2016 Feb; 35(2):246-51. PubMed ID: 25546568
[TBL] [Abstract][Full Text] [Related]
15. What uro-gynecologists should know about sacral neuromodulation (SNM) for the treatment of refractory overactive bladder.
Oelke M; Addali M; Reisenauer C
Arch Gynecol Obstet; 2019 May; 299(5):1243-1252. PubMed ID: 30941558
[TBL] [Abstract][Full Text] [Related]
16. Effects of sacral neuromodulation on isolated urinary bladder function in a rat model of spinal cord injury.
Kumsar Ş; Keskin U; Akay A; Bilgilisoy UT; Erdem ŞR; Peşkircioğlu ÇL; Özkardeş H
Neuromodulation; 2015 Jan; 18(1):67-74; discussion 74-5. PubMed ID: 24917133
[TBL] [Abstract][Full Text] [Related]
17. Chronic sacral neuromodulation for treatment of neurogenic bladder dysfunction: long-term results with unilateral implants.
Hohenfellner M; Humke J; Hampel C; Dahms S; Matzel K; Roth S; Thüroff JW; Schultz-Lampel D
Urology; 2001 Dec; 58(6):887-92. PubMed ID: 11744452
[TBL] [Abstract][Full Text] [Related]
18. [Chronic sacral bilateral neuromodulation. Using a minimal invasive implantation technique in patients with disorders of bladder function].
Braun PM; Seif C; Scheepe JR; Martinez Portillo FJ; Bross S; Alken P; Jünemann KP
Urologe A; 2002 Jan; 41(1):44-7. PubMed ID: 11963774
[TBL] [Abstract][Full Text] [Related]
19. A new minimally invasive procedure for pudendal nerve stimulation to treat neurogenic bladder: description of the method and preliminary data.
Spinelli M; Malaguti S; Giardiello G; Lazzeri M; Tarantola J; Van Den Hombergh U
Neurourol Urodyn; 2005; 24(4):305-9. PubMed ID: 15977260
[TBL] [Abstract][Full Text] [Related]
20. The sacral anterior root stimulator as a means of managing the bladder in patients with spinal cord lesions.
Brindley GS
Baillieres Clin Neurol; 1995 Apr; 4(1):1-13. PubMed ID: 7633777
[No Abstract] [Full Text] [Related]
[Next] [New Search]
